Bain Capital Life Sciences Investors, LLC Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$1.3B

Holdings

19

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (19 positions)

#StockSharesValue% PortfolioType
1
HTFLHEARTFLOW INC
12,448,158$362.9M27.79%
2
NAMSNEWAMSTERDAM PHARMA COMPANY
7,306,566$256.3M19.63%
3
OLMAOLEMA PHARMACEUTICALS INC
8,508,641$212.7M16.29%
4
YB4PSAVARA INC
17,600,621$106.1M8.13%
5
PHVSPHARVARIS N V
2,802,081$77.8M5.96%
6
SLDBSOLID BIOSCIENCES INC
7,911,669$44.6M3.42%
7
UPBUPSTREAM BIO INC
1,329,544$36.1M2.76%
8
XFORX4 PHARMACEUTICALS INC
7,967,454$31.9M2.44%
9
DNTHDIANTHUS THERAPEUTICS INC
743,592$30.6M2.35%
10
KYTXKYVERNA THERAPEUTICS INC
3,110,000$29.2M2.24%
11
ANNXANNEXON INC
5,249,069$26.4M2.02%
12
RPIDRAPID MICRO BIOSYSTEMS INC
8,434,560$24.5M1.87%
13
CABACABALETTA BIO INC
9,677,125$21.2M1.62%
14
CCCCC4 THERAPEUTICS INC
7,171,910$13.7M1.05%
15
MRSNMERSANA THERAPEUTICS INC
346,545$10.0M0.77%
16
AVIRATEA PHARMACEUTICALS INC
2,485,638$8.9M0.68%
17
TNGXTANGO THERAPEUTICS INC
653,493$5.8M0.44%
18
XLOXILIO THERAPEUTICS INC
7,372,686$4.7M0.36%
19
NAMSNEWAMSTERDAM PHARMA COMPANY
99,999$2.3M0.18%